Liquidia Co. (NASDAQ:LQDA - Get Free Report)'s stock price rose 15% during mid-day trading on Friday . The company traded as high as $15.38 and last traded at $16.07. Approximately 701,299 shares changed hands during trading, a decline of 28% from the average daily volume of 975,597 shares. The stock had previously closed at $13.98.
Wall Street Analysts Forecast Growth
LQDA has been the subject of several research reports. HC Wainwright restated a "buy" rating and set a $29.00 price objective on shares of Liquidia in a research report on Thursday, March 20th. Needham & Company LLC reaffirmed a "buy" rating and issued a $25.00 price target on shares of Liquidia in a report on Thursday, April 10th. Finally, Scotiabank increased their price objective on Liquidia from $34.00 to $36.00 and gave the company a "sector outperform" rating in a research report on Monday. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Liquidia has a consensus rating of "Buy" and an average target price of $26.88.
Get Our Latest Report on Liquidia
Liquidia Stock Down 3.4 %
The stock has a market capitalization of $1.33 billion, a PE ratio of -9.55 and a beta of 0.24. The stock's 50-day moving average is $14.23 and its 200 day moving average is $13.06.
Liquidia (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.08). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The firm had revenue of $2.92 million for the quarter, compared to analyst estimates of $4.60 million. As a group, equities research analysts forecast that Liquidia Co. will post -1.51 EPS for the current year.
Insider Buying and Selling
In other news, insider Rajeev Saggar sold 2,450 shares of the company's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $13.67, for a total transaction of $33,491.50. Following the completion of the sale, the insider now owns 263,152 shares in the company, valued at approximately $3,597,287.84. This represents a 0.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Jason Adair sold 1,856 shares of the firm's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $25,185.92. Following the completion of the transaction, the insider now directly owns 184,304 shares in the company, valued at $2,501,005.28. The trade was a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,138 shares of company stock worth $450,233. Insiders own 30.10% of the company's stock.
Institutional Trading of Liquidia
A number of institutional investors and hedge funds have recently modified their holdings of the company. Corebridge Financial Inc. grew its holdings in Liquidia by 2.3% in the 4th quarter. Corebridge Financial Inc. now owns 31,516 shares of the company's stock valued at $371,000 after buying an additional 694 shares during the last quarter. Catalina Capital Group LLC grew its stake in shares of Liquidia by 6.5% in the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company's stock worth $215,000 after acquiring an additional 1,125 shares during the last quarter. GAMMA Investing LLC increased its position in Liquidia by 65.6% during the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock worth $44,000 after acquiring an additional 1,173 shares during the period. Cetera Investment Advisers increased its position in Liquidia by 4.3% during the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock worth $367,000 after acquiring an additional 1,277 shares during the period. Finally, Valmark Advisers Inc. raised its stake in Liquidia by 7.4% during the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company's stock valued at $275,000 after purchasing an additional 1,283 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.
Liquidia Company Profile
(
Get Free Report)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Further Reading
Before you consider Liquidia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.
While Liquidia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
